Anne Sonet

4.6k total citations · 1 hit paper
64 papers, 2.2k citations indexed

About

Anne Sonet is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Anne Sonet has authored 64 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pathology and Forensic Medicine, 26 papers in Oncology and 21 papers in Genetics. Recurrent topics in Anne Sonet's work include Lymphoma Diagnosis and Treatment (39 papers), Chronic Lymphocytic Leukemia Research (16 papers) and Viral-associated cancers and disorders (14 papers). Anne Sonet is often cited by papers focused on Lymphoma Diagnosis and Treatment (39 papers), Chronic Lymphocytic Leukemia Research (16 papers) and Viral-associated cancers and disorders (14 papers). Anne Sonet collaborates with scholars based in Belgium, France and United States. Anne Sonet's co-authors include Gilles Salles, Bertrand Coiffier, Nicolas Mounier, Corinne Haïoun, André Bosly, F Reyes, Daniel Espinouse, Hervé Tilly, Serge Bologna and Y Bastion and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Anne Sonet

61 papers receiving 2.1k citations

Hit Papers

Posaconazole versus voriconazole for primary treatment of... 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial
    2021 161 citations Johan Maertens, Galia Rahav et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Sonet Belgium 22 1.3k 873 589 452 396 64 2.2k
Wilhelm Woessmann Germany 26 1.2k 0.9× 740 0.8× 314 0.5× 233 0.5× 450 1.1× 65 2.0k
John P. Greer United States 31 1.5k 1.1× 1.3k 1.5× 556 0.9× 203 0.4× 379 1.0× 119 3.3k
Barry I. Samuels United States 21 1.5k 1.1× 1.3k 1.5× 739 1.3× 401 0.9× 194 0.5× 69 2.7k
TP Miller United States 22 1.8k 1.4× 2.0k 2.3× 695 1.2× 377 0.8× 508 1.3× 28 3.3k
Tak Takvorian United States 27 1.5k 1.2× 1.1k 1.2× 899 1.5× 362 0.8× 529 1.3× 58 2.9k
Aspasia Stamatoullas France 34 1.7k 1.3× 1.3k 1.5× 1.2k 2.0× 289 0.6× 449 1.1× 126 3.6k
Marcel Reiser Germany 28 2.5k 1.9× 1.9k 2.2× 1.3k 2.2× 519 1.1× 714 1.8× 124 3.6k
Andreas H. Sarris United States 30 2.4k 1.8× 1.5k 1.8× 1.0k 1.7× 416 0.9× 488 1.2× 67 3.3k
Pauline Brice France 23 2.3k 1.7× 1.4k 1.6× 546 0.9× 467 1.0× 722 1.8× 75 3.1k
Patrizio Mazza Italy 22 1.1k 0.8× 680 0.8× 516 0.9× 248 0.5× 387 1.0× 98 1.8k

Countries citing papers authored by Anne Sonet

Since Specialization
Citations

This map shows the geographic impact of Anne Sonet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Sonet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Sonet more than expected).

Fields of papers citing papers by Anne Sonet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Sonet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Sonet. The network helps show where Anne Sonet may publish in the future.

Co-authorship network of co-authors of Anne Sonet

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Sonet. A scholar is included among the top collaborators of Anne Sonet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Sonet. Anne Sonet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Montesinos, Isabel, Te‐Din Huang, Pierre Bogaerts, et al.. (2024). Diagnostic Value of Serum Biomarkers for Invasive Aspergillosis in Haematologic Patients. Journal of Fungi. 10(9). 661–661. 1 indexed citations
2.
Maertens, Johan, Galia Rahav, Dong‐Gun Lee, et al.. (2021). Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial. The Lancet. 397(10273). 499–509. 161 indexed citations breakdown →
3.
Morel, Alexandre, Josette Brière, Laurence Lamant, et al.. (2017). Long-term outcomes of adults with first-relapsed/refractory systemic anaplastic large-cell lymphoma in the pre-brentuximab vedotin era: A LYSA/SFGM-TC study. European Journal of Cancer. 83. 146–153. 15 indexed citations
4.
Bachy, Emmanuel, Roch Houot, F. Morschhauser, et al.. (2013). Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma. Haematologica. 98(7). 1107–1114. 60 indexed citations
5.
Hoof, Ambro van, Daan Dierickx, Virginie De Wilde, et al.. (2013). Treatment of peripheral T-cell lymphomas: recommendations of the Belgian Hematological Society (BHS).. Open Repository and Bibliography (University of Liège). 4(3). 90–101.
6.
7.
Hoof, Ambro van, Anne Sonet, Christophe Bonnet, et al.. (2012). Guidelines of the Belgian hamatological Society for newly diagnosed and relapsed follicular lymphoma 2012.. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 3(2). 41–50. 1 indexed citations
8.
Potting, Carin, Walter J. F. M. van der Velden, Koen Theunissen, et al.. (2012). Caphosol in prevention of oral mucositis in autologous stem cell transplant recipients after high-dose melphalan (CASH). Bone Marrow Transplantation. 47. 2 indexed citations
9.
Sibon, David, Marion Fournier, Josette Brière, et al.. (2012). Long-Term Outcome of Adults With Systemic Anaplastic Large-Cell Lymphoma Treated Within the Groupe d'Étude des Lymphomes de l'Adulte Trials. Journal of Clinical Oncology. 30(32). 3939–3946. 126 indexed citations
10.
Osselaer, Jean‐Claude, Chantal Doyen, C Chatelain, et al.. (2006). Impact of photochemical treatment (intercept) on platelet use in routine practice. Digital Access to Libraries. 91. 180–180. 1 indexed citations
11.
Sonet, Anne, Ambro van Hoof, Nicole Straetmans, et al.. (2006). Palifermin Treatment in Patients Receiving High Dose Melphalan or BEAM Prior to Autologous Peripheral Blood Stem-Cell Transplantation.. Blood. 108(11). 5241–5241. 6 indexed citations
12.
Krug, Bruno, et al.. (2004). FDG PET Utility in Paraneoplastic Sweet Syndrome. Clinical Nuclear Medicine. 29(2). 91–92. 14 indexed citations
13.
Coiffier, Bertrand, Nicolas Mounier, Serge Bologna, et al.. (2002). Final results of the efficacy and safety of rasburicase (recombinant urate oxydase) for the prevention and treatment of hyperuricemia in patients with aggressive lymphoma (GRAAL 1 study).. Blood. 100(11). 4 indexed citations
14.
André, Marc, Nicolas Mounier, Xavier Leleu, et al.. (2001). Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma (NHL) with the ACVBP regimen. A GELA (Groupe d'Etude des Lymphomes de l'Adulte) cohort study on 2849 patients.. Blood. 98(11). 4 indexed citations
15.
Neste, Eric Van Den, Jl. Michaux, André Delannoy, et al.. (2000). Phase I/II study of 2-chloro-2′-deoxyadenosine with cyclophosphamide in patients with pretreated B cell chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma. Leukemia. 14(6). 1136–1142. 35 indexed citations
16.
Ketterer, Nicolas, Gilles Salles, Michel Raba, et al.. (1998). High CD34+ Cell Counts Decrease Hematologic Toxicity of Autologous Peripheral Blood Progenitor Cell Transplantation. Blood. 91(9). 3148–3155. 2 indexed citations
17.
Bosly, André, et al.. (1997). Superiority of late over early intensification in relapsing/refractory aggressive non-Hodgkin's lymphoma: A randomized study from the GELA: LNH RP 93. British Journal of Haematology. 102(1). 148–148. 7 indexed citations
18.
Bosly, André, Anne Sonet, Gilles Salles, et al.. (1997). Late intensification is superior to early intensification in relapsing/refractory aggressive non-Hodgkin's lymphoma. A randomized study from the GELA: LNH RP93.. Experimental Hematology. 25(8). 16–16. 1 indexed citations
19.
Cornélis, F., Anne Sonet, Chantal Doyen, et al.. (1996). Acute leukaemia in paroxysmal nocturnal haemoglobinuria. Case report and review of the literature. PubMed. 38(3). 285–288. 5 indexed citations
20.
Bosly, André, Augustin Ferrant, Anne Sonet, et al.. (1995). 2-Chlorodeoxyadenosine in refractory non-Hodgkin's lymphoma: A phase II study on 50 patients.. Blood. 86(10). 212–212. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wilhelm Woessmann Breakdown of academic impact, for papers by John P. Greer Breakdown of academic impact, for papers by Barry I. Samuels Breakdown of academic impact, for papers by TP Miller Breakdown of academic impact, for papers by Tak Takvorian Breakdown of academic impact, for papers by Aspasia Stamatoullas Breakdown of academic impact, for papers by Marcel Reiser Breakdown of academic impact, for papers by Andreas H. Sarris Breakdown of academic impact, for papers by Pauline Brice Breakdown of academic impact, for papers by Patrizio Mazza
Rankless by CCL
2026